fashion -WSS

fashion

author：Wikipedia 2025-09-27 22:32:11 - browse：462

Morgan Griffith -- health policy coverage from STAT — At a Wednesday hearing, Oversight subcommittee Chair Morgan Griffith (R-Va.) mocked Medicare drug price negotiation as “godfather mafia-style negotiation.” Anna Moneymaker/Getty Images

WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at a House hearing, with the former accusing the latter of setting up “mafia-style” theft of property.

Typically, intense hearings like the one before the House Energy and Commerce subcommittee take place when lawmakers are debating legislation, not well after a law passes.

Despite the popularity of Medicare drug price negotiation with voters in both parties, Republicans have attacked the law, known as the Inflation Reduction Act, since Democrats passed it last year. Republicans lawmakers and drugmakers say the drug pricing reforms included in the legislation, which empower Medicare to directly negotiate the prices of some medicines, are tantamount to government price setting and will lead to fewer new drugs. The industry is challenging the program as unconstitutional in multiple courts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Elizabeth Holmes banned from government health programs

hotspot

WSS

Why doctors need education on FDA device approval process

My yearlong odyssey to get my son’s ADHD medication covered

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Latigo launches with $135 million for Vertex

Juul documents reveal insider tactics on political lobbying

Websites selling Wegovy, Zepbound ingredients targeted by FDA

focus

fashion

focus

Anesthesiologist group: stop taking Ozempic before surgery

Eli Lilly, Pfizer, and others want in on the online prescription market

Medicare details structure of new drug price negotiation program

Prior authorization will have to move faster under new Biden rule

How to save PrEP access — and even expand it

Report cites 'urgent' need to recruit more diverse clinical trial participants

Wildfire smoke exposes gaps in outdoor worker protections

Tome Biosciences co

Supreme Court strikes down use of affirmative action

Too many hospitalized Covid

knowledge

NIH director takes cautious approach to Biden drug pricing priority

Latigo launches with $135 million for Vertex

Eli Lilly, Pfizer, and others want in on the online prescription market

Medicare Advantage today, explained in one chart

Artificial intelligence use in health care faces greater scrutiny in 2024

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

focus

Wikipedia

hotspot

explore